Monaco, L.; Gemelli, M.; Gotuzzo, I.; Bauckneht, M.; Crivellaro, C.; Genova, C.; Cortinovis, D.; Zullo, L.; Ammoni, L.C.; Bernasconi, D.P.;
et al. Metabolic Parameters as Biomarkers of Response to Immunotherapy and Prognosis in Non-Small Cell Lung Cancer (NSCLC): A Real World Experience. Cancers 2021, 13, 1634.
https://doi.org/10.3390/cancers13071634
AMA Style
Monaco L, Gemelli M, Gotuzzo I, Bauckneht M, Crivellaro C, Genova C, Cortinovis D, Zullo L, Ammoni LC, Bernasconi DP,
et al. Metabolic Parameters as Biomarkers of Response to Immunotherapy and Prognosis in Non-Small Cell Lung Cancer (NSCLC): A Real World Experience. Cancers. 2021; 13(7):1634.
https://doi.org/10.3390/cancers13071634
Chicago/Turabian Style
Monaco, Lavinia, Maria Gemelli, Irene Gotuzzo, Matteo Bauckneht, Cinzia Crivellaro, Carlo Genova, Diego Cortinovis, Lodovica Zullo, Luca Carlofrancesco Ammoni, Davide Paolo Bernasconi,
and et al. 2021. "Metabolic Parameters as Biomarkers of Response to Immunotherapy and Prognosis in Non-Small Cell Lung Cancer (NSCLC): A Real World Experience" Cancers 13, no. 7: 1634.
https://doi.org/10.3390/cancers13071634
APA Style
Monaco, L., Gemelli, M., Gotuzzo, I., Bauckneht, M., Crivellaro, C., Genova, C., Cortinovis, D., Zullo, L., Ammoni, L. C., Bernasconi, D. P., Rossi, G., Morbelli, S., & Guerra, L.
(2021). Metabolic Parameters as Biomarkers of Response to Immunotherapy and Prognosis in Non-Small Cell Lung Cancer (NSCLC): A Real World Experience. Cancers, 13(7), 1634.
https://doi.org/10.3390/cancers13071634
